4//SEC Filing
Schroeder Mark S 4
Accession 0001127602-25-010624
CIK 0000920148other
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 10:39 AM ET
Size
7.9 KB
Accession
0001127602-25-010624
Insider Transaction Report
Form 4
Schroeder Mark S
EVP, Pres Diagnostics & COO
Transactions
- Award
Common Stock
2025-03-27+4,840→ 9,800.143 total - Tax Payment
Common Stock
2025-03-27$231.67/sh−2,205$510,832→ 7,595.143 total - Sale
Common Stock
2025-03-28$231.67/sh−2,635$610,450→ 4,960.143 total
Footnotes (3)
- [F1]Shares acquired on March 27, 2025, pursuant to a performance award granted on February 11, 2022, relating to performance during the three-year period ended December 31, 2024.
- [F2]Stock withholding to satisfy tax withholding obligations.
- [F3]Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
Documents
Issuer
LABCORP HOLDINGS INC.
CIK 0000920148
Entity typeother
Related Parties
1- filerCIK 0001793112
Filing Metadata
- Form type
- 4
- Filed
- Mar 30, 8:00 PM ET
- Accepted
- Mar 31, 10:39 AM ET
- Size
- 7.9 KB